Table 3 Subject’s Medication at Baseline
Medication | Walking (W) only (n=79) | Walking and Behavioural (WB) (n=69) | Self-directed (C) (n=74) |
|---|---|---|---|
Oral hypoglycaemic agents | Â | Â | Â |
  Total | 2 (3) | 5 (7) | 9 (12) |
  Biguanide Class | 2 (3) | 4 (6) | 9 (12) |
  Sulfonylureas Class | 0 (0) | 0 (0) | 2 (3) |
  Thiazolidinedione | 0 (0) | 2 (3) | 2 (3) |
Antihypertensive Agents | Â | Â | Â |
  Total | 22 (28) | 15 (22) | 15 (22) |
  Calcium channel blockers | 6(8) | 0(0) | 7(9) |
  Antiotensin-converting enzyme | 3 (4) | 7 (10) | 7 (9) |
  Angiotensin II receptor blockers | 6 (8) | 6 (9) | 3 (4) |
  Beta-blocker | 4 (5) | 3 (4) | 4 (5) |
  Alpha-blocker | 3 (4) | 0 (0) | 0 (0) |
  Diuretic | 5 (6) | 8 (12) | 5 (7) |
Antiarrhythmic | 1 (1) | 0 (0) | 0 (0) |
Anti-anginal | 1 (1) | 0 (0) | 0 (0) |
Anti-platelet agent | 1 (1) | 1 (1) | 1 (1) |
Anticoagulant | 0 (0) | 2 (3) | 0 (0) |
Phosphodiesterase type 5 inhibitors | 0 (0) | 1 (1) | 0 (0) |
Statins | 8 (10) | 12 (17) | 10 (14) |
Hormone | Â | Â | Â |
  Total | 11 (14) | 10 (14) | 11 (15) |
  Thyroid | 5 (6) | 5 (7) | 8 (11) |
  Insulin | 0 (0) | 3 (4) | 1 (1) |
  Corticosteroid | 4 (5) | 2 (3) | 3 (4) |
  Progesterone | 1 (1) | 0 (0) | 1 (1) |
  Androgen | 1 (1) | 0 (0) | 0 (0) |
  Oestrogen | 1 (1) | 0 (0) | 0 (0) |
Antithyroid | 0 (0) | 1 (1) | 0(0) |
SERMs (Selective estrogen receptor modifiers) | 1 (1) | 0 (0) | 0 (0) |
Beta 2-adrenergic receptor agonist (bronchodilator) | 2(3) | 1 (1) | 3 (4) |
NSAIDs (Non-steroid anti-inflammatory drugs) | 26 (33) | 21 (30) | 18 (24) |
COX-2 selective inhibitor | 3 (4) | 4 (6) | 1 (1) |
NSAIDS | Â | Â | Â |
Betahistine | 0 (0) | 1 (1) | 0 (0) |
DMARDs (Disease modifying antirheumatic drugs) | 0 (0) | 1 (1) | 0 (0) |
Histamine antagonist | 0 (0) | 2 (3) | 0 (0) |
Bisphosphonate | 6 (8) | 4 (6) | 4 (5) |
Antibiotics | 2 (3) | 1 (1) | 4 (5) |
Analgesics | 1 (1) | 1 (1) | 3 (4) |
Opiates | 0 (0) | 0 (0) | 2 (3) |
Hypnotic | 4 (5) | 3 (4) | 4 (5) |
Antidepressant | 7 (9) | 5 (7) | 7 (9) |
Psychostimulant | 0 (0) | 1 (1) | 0 (0) |
Antipsychotic | 0 (0) | 1 (1) | 0 (0) |
Anti-manic | 0 (0) | 1 (1) | 0 (0) |
Anti-convulsant | 1 (1) | 1 (1) | 0 (0) |
Protein pump inhibitor (PPI) | 9 (11) | 5 (6) | 6 (8) |
Enzyme inhibitor | 0 (0) | 1 (1) | 2 (3) |
Muscle relaxant | 0 (0) | 1 (1) | 1 (1) |
Antispasmodic | 0 (0) | 1 (1) | 0 (0) |
Anti-cholinergic | 1 (1) | 1 (1) | 0 (0) |
Antineoplastic | 2 (3) | 1 (1) | 0 (0) |
Antimetabolite | 1 (1) | 1 (1) | 1 (1) |
Antifolate | 0 (0) | 1 (1) | 1 (1) |
Latanoprost | 0 (0) | 1 (1) | 0 (0) |
Viscosupplementation | 0 (0) | 1 (1) | 0 (0) |
Xanthine | 1 (1) | 0 (0) | 0 (0) |
Antifungals | 0 (0) | 0 (0) | 1 (1) |
Antimalarial | 0 (0) | 1 (1) | 1 (1) |
Nitrate | 0 (0) | 0 (0) | 2 (3) |
Laxative | 0 (0) | 0 (0) | 2 (3) |
Supplements | 22 (28) | 22 (28) | 18 (24) |
Homeopathic Medication | 1 (1) | 1 (1) | 1 (1) |
None | 11 (14) | 10 (13) | 9 (12) |
Not Specific | 21 (27) | 21 (27) | 20 (27) |
Missing Data | Â | Â | Â |
  Total | 4 (5) | 8 (10) | 17 (23) |
  No Evaluation* | 2 (3) | 4 (5) | 7 (9) |
  No File** | 2 (3) | 4 (6) | 10 (14) |